Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
1,088.70
1,137.76
1,125.36
1,127.72
1,086.81
943.37
963.01
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,088.70
1,137.76
1,125.36
1,127.72
1,086.81
943.37
963.01
Raw Material Cost
514.07
524.59
523.46
527.51
491.03
419.83
426.35
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
42.34
47.63
67.16
69.16
61.86
77.57
96.57
Selling and Distribution Expenses
265.23
263.93
259.47
252.41
265.86
226.13
236.31
Other Expenses
-4.23
-4.76
-6.72
-6.92
-6.19
-7.76
-9.66
Total Expenditure (Excl Depreciation)
779.30
788.52
782.93
779.92
756.89
645.96
662.65
Operating Profit (PBDIT) excl Other Income
309.40000000000003
349.20000000000005
342.40000000000003
347.8
329.90000000000003
297.4
300.4
Other Income
-9.57
-4.95
0.76
-2.34
-3.48
-1.05
-1.28
Operating Profit (PBDIT)
331.11
374.46
373.86
384.40
365.24
333.60
336.85
Interest
42.34
47.63
67.16
69.16
61.86
77.57
96.57
Exceptional Items
0.00
-12.47
0.00
-370.22
-2.12
-14.67
-11.36
Gross Profit (PBDT)
574.64
613.17
601.90
600.22
595.78
523.53
536.66
Depreciation
31.27
30.17
30.68
38.94
38.80
37.25
37.78
Profit Before Tax
257.50
284.19
276.02
-93.92
262.46
204.11
191.15
Tax
67.19
69.58
66.69
-11.61
57.08
39.43
48.87
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
190.30
214.60
209.34
-82.31
205.38
164.68
142.28
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
190.30
214.60
209.34
-82.31
205.38
164.68
142.28
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
190.30
214.60
209.34
-82.31
205.38
164.68
142.28
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
1,887.52
1,834.90
1,655.08
1,447.08
1,577.61
1,358.30
1,170.97
Earnings per share (EPS)
3.91
4.29
4.17
-1.65
4.04
3.25
2.78
Diluted Earnings per share
3.91
4.29
4.17
-1.65
4.04
3.25
2.78
Operating Profit Margin (Excl OI)
28.42%
30.7%
30.43%
30.84%
30.36%
31.53%
31.19%
Gross Profit Margin
26.52%
27.63%
27.25%
-4.88%
27.72%
25.58%
23.77%
PAT Margin
17.48%
18.86%
18.6%
-7.3%
18.9%
17.46%
14.77%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is -4.32% vs 1.10% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is -11.32% vs 2.53% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -10.20% vs 1.69% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -11.13% vs -29.17% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Prestige Consumer Healthcare, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
1,088.70
0
1,088.70
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,088.70
0
1,088.70
Raw Material Cost
514.07
0
514.07
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
42.34
0
42.34
Selling and Distribution Expenses
265.23
0
265.23
Other Expenses
-4.23
0.00
-4.23
Total Expenditure (Excl Depreciation)
779.30
0
779.30
Operating Profit (PBDIT) excl Other Income
309.41
0.00
309.41
Other Income
-9.57
0
-9.57
Operating Profit (PBDIT)
331.11
0
331.11
Interest
42.34
0
42.34
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
574.64
0
574.64
Depreciation
31.27
0
31.27
Profit Before Tax
257.50
0
257.50
Tax
67.19
0
67.19
Provisions and contingencies
0
0
0.00
Profit After Tax
190.30
0
190.30
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
190.30
0
190.30
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
190.30
0
190.30
Equity Capital
0
0
0.00
Face Value
0.01
0
0.00
Reserves
1,887.52
0
1,887.52
Earnings per share (EPS)
3.91
0
3.91
Diluted Earnings per share
3.91
0
3.91
Operating Profit Margin (Excl OI)
28.42%
0%
0.00
28.42%
Gross Profit Margin
26.52%
0%
0.00
26.52%
PAT Margin
17.48%
0%
0.00
17.48%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 108.87 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is -4.32% vs 1.10% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 19.03 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is -11.32% vs 2.53% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 34.07 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is -10.20% vs 1.69% in Mar 2025
Annual - Interest
Interest 4.23 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is -11.13% vs -29.17% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.42%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025






